-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, O/eMMwxSU81iiinAJ0LqRLgyUe699N0IwtA2fgp+Ud9vPdiQnqAp08Mx5WcKhZM3 0AHGBDJ7xWjI9ZRuKcS98Q== 0000950130-96-003823.txt : 19961009 0000950130-96-003823.hdr.sgml : 19961009 ACCESSION NUMBER: 0000950130-96-003823 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19961003 ITEM INFORMATION: Other events FILED AS OF DATE: 19961008 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: ROBERTS PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0000853022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222429994 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-10432 FILM NUMBER: 96640484 BUSINESS ADDRESS: STREET 1: MERIDIAN CENTRE II STREET 2: 4 INDUSTRIAL WAY W CITY: EATONTOWN STATE: NJ ZIP: 07724 BUSINESS PHONE: 9083891182 MAIL ADDRESS: STREET 1: MERIDIAN CTR II STREET 2: 4 INDUSTRIAL WAY WEST CITY: EATONTOWN STATE: NJ ZIP: 07724 8-K 1 FORM 8-K FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 3, 1996 ROBERTS PHARMACEUTICAL CORPORATION - -------------------------------------------------------------------------------- (exact name of registrant as specified in its charter) New Jersey 1-1-432 22-2429994 -------------------- ---------------- -------------------- (State or other (Commission (IRS Employer jurisdiction of File Number) Identification incorporation) Number) Meridian Center II 4 Industrial Way West Eatontown, New Jersey 07724 - -------------------------------------------------------------------------------- (Address of principal executive offices, including zip code) Registrant's telephone number, including area code: 908-389-1182 Meridian Center II 4 Industrial Way West Eatontown, New Jersey 07724 - -------------------------------------------------------------------------------- (Former name or former address, if changed from last report) - 2 - Item 5. Other Events ------------ Roberts Pharmaceutical Corporation announced today that Monarch Pharmaceuticals, a division of King Pharmaceuticals of Bristol, Tennessee, has acquired two separate respiratory care product lines from Roberts. The two product lines involved in the acquisition are Nucofed(R) and Quibron(R). The Nucofed(R) family of products consists of four separate dosage forms, all of which are indicated for the symptomatic relief of coughing and congestion associated with respiratory infections and related conditions such as the common cold, bronchitis, influenza, and sinusitis. The Quibron(R) family, consisting of four separate dosage forms is indicated for relief and/or prevention of symptoms of asthma and reversible bronchospasm associated with chronic bronchitis and emphysema. The sale of these two product lines is in keeping with Roberts plans to divest certain brands in order to concentrate on the commercialization of Roberts' pipeline. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ROBERTS PHARMACEUTICAL CORPORATION ---------------------------------- (Registrant) Date: October 8, 1996 By: /s/ Anthony A. Rascio ---------------------------- Anthony A. Rascio Vice President -----END PRIVACY-ENHANCED MESSAGE-----